Persistent Positivity of Reverse Transcriptase-Polymerase Chain Reaction Test among Patients with COVID-19 in Rural Teaching Hospital: A Descriptive Cross-sectional Study.
COVID-19; recurrence; reverse transcriptase-polymerase chain reaction; SARS-CoV-2; viral shedding.
Journal
JNMA; journal of the Nepal Medical Association
ISSN: 1815-672X
Titre abrégé: JNMA J Nepal Med Assoc
Pays: Nepal
ID NLM: 0045233
Informations de publication
Date de publication:
15 Nov 2021
15 Nov 2021
Historique:
received:
06
09
2021
accepted:
17
11
2021
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
The persistence positivity detected for severe acute respiratory syndrome coronavirus 2 ribonucleic acid by real-time reverse transcriptase-polymerase chain reaction test in asymptomatic coronavirus disease 2019 positive patients has attracted a lot of attention. There is limited data on the duration of viral shedding. We aimed to determine the proportion of coronavirus disease patients with persistent positivity of real-time reverse transcriptase-polymerase chain reaction test in a teaching hospital of Nepal. A descriptive cross-sectional study was conducted using medical records from May to September 2020 in a teaching hospital of Nepal. The study was approved by the Institutional Review Committee of Karnali Academy of Health Sciences (Reference no 077/078/03). Convenient sampling method was used. Data was analysed by Statistical Package for the Social Sciences. Point estimate at 90% Confidence Interval was calculated along with frequency and proportion for binary data. Of the total 95 cases, 9 (9.5%) cases (4.6-14.4 at 90% Confidence Interval), were repeat positive after achieving the first negative. The mean day required of achieving the last negative for the repeat positive group was 62.11±3.95, range (60-70 days). The mean time duration for the virus shedding was found to be 20.43±12.19 days (range 7-60 days) after the first positive test result. This study concludes that there might be a persistent positivity of the polymerase chain reaction test among patients with COVID-19. The majority of the patients were test positive for 8-14 days, and some were positive till 60-70 days.
Identifiants
pubmed: 35199749
doi: 10.31729/jnma.7077
pmc: PMC9124342
doi:
Substances chimiques
RNA-Directed DNA Polymerase
EC 2.7.7.49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1136-1140Références
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Med Virol. 2020 Oct;92(10):2227-2231
pubmed: 32484958
Infect Dis (Lond). 2021 Jan;53(1):31-37
pubmed: 32935628
BMJ Case Rep. 2021 Mar 3;14(3):
pubmed: 33658220
Microorganisms. 2020 Jul 26;8(8):
pubmed: 32722621
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
QJM. 2020 Aug 1;113(8):556-560
pubmed: 32609360
Acute Med Surg. 2020 Jun 10;7(1):e525
pubmed: 32528710
J Med Virol. 2020 Oct;92(10):1755-1756
pubmed: 32270882
J Infect. 2020 Jul;81(1):e78-e79
pubmed: 32283161
J Med Case Rep. 2020 Oct 7;14(1):191
pubmed: 33028403
Biomed Res Int. 2021 Feb 26;2021:5909612
pubmed: 33728332
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Am J Infect Control. 2021 Mar;49(3):293-298
pubmed: 32827597
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
JNMA J Nepal Med Assoc. 2020 Nov 22;58(231):918-922
pubmed: 34506421
J Clin Virol. 2020 Aug;129:104477
pubmed: 32505778
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
Ann Transl Med. 2020 Sep;8(17):1084
pubmed: 33145303
Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6
pubmed: 32653662